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Long-term survival of the pathogen 
Mycobacterium tuberculosis in humans is 
linked to the immunomodulatory potential of 
its complex cell wall glycolipids, which 
include the phosphatidylinositol mannoside 
(PIM) series as well as the related 
lipomannan and lipoarabinomannan 
glycoconjugates. PIM biosynthesis is initiated 
by a set of cytosolic -mannosyltransferases, 
catalysing glycosyl transfer from the 
activated saccharide donor GDP-Man to the 
acceptor phosphatidyl-myo-inositol (PI) in an 
ordered and regio-specific fashion. Herein, 
we report the crystal structure of 
mannosyltransferase Corynebacterium 
glutamicum PimB' in complex with nucleotide 
to a resolution of 2.0 Å. PimB' attaches 
mannosyl selectively to the 6-OH of the 
inositol moiety of PI. Two crystal forms and 
GDP- versus GDP-Man-bound complexes 
reveal flexibility of the nucleotide 
conformation as well as of the structural 
framework of the active site. Structural 
comparison, docking of the saccharide 
acceptor and site directed mutagenesis pin 
regio-selectivity to a conserved Asp residue in 
the N-terminal domain that forces 
presentation of the correct inositol hydroxyl 
to the saccharide donor.  
The cell envelope of Mycobacterium 
tuberculosis, the infectious agent causing 
tuberculosis (TB), contains a variety of 
glycolipids that play a central role in subverting 
the host's immune response, and thus help 
establish a long-lasting latent infection, a 
hallmark of the pathophysiology of TB (1, 2). 
Phosphatidylinositol mannosides (PIM) 
represent a series of glycolipids that comprise a 
phosphatidyl-myo-inositol (PI) core, an acylated 
mannosyl group attached to the 2-hydroxyl of 
inositol, and a mannosyl-oligosaccharide of 
variable length attached to the inositol 6-
hydroxyl (Fig. 1) (3). A precursor of the more 
complex lipomannan (LM) and 
lipoarabinomannan (LAM) glycolipids, PIM 
have been shown to influence both innate (4, 5) 
and adaptive immunity of the host (6-9).  
PIM biosynthesis begins by consecutive 
transfer of two mannosyl-units from activated 
sugar-nucleotide (GDP-Man) to PI, catalyzed by 
cytoplasmic -mannosyltransferases (Fig. 1). 
Attachment of the first mannosyl residue to the 
2-hydroxyl of the inositol ring, resulting in 
PIM1, is catalyzed by PimA (M. tuberculosis 
Rv2610c, Mycobacterium smegmatis 
MSMEG_2935) (10, 11), followed by acylation 
of the 2-mannose (by M. tuberculosis Rv2611c) 
(12) to yield mono-acylated PIM1 (Ac1PIM1). 
The second mannosyl residue is attached at the 
6-hydroxyl, to yield Ac1PIM2, a reaction 
catalyzed by PimB' (M. tuberculosis Rv2188c, 
M. smegmatis MSMEG_4253, Corynebacterium 
glutamicum NCgl2106) (13-15). The 
designation PimB had originally been assigned 
to open reading frame Rv0557, also encoding an 
-mannosyltransferase. Subsequently, Rv0557 
was found to be dispensable for synthesis of 
Ac1PIM2 and the corresponding protein has 
since been renamed MgtA (15-17). For 
consistency with the recent literature, we retain 
the designation PimB' for Rv2188c (and its 
orthologs in M. smegmatis and C. glutamicum) 
(14, 15, 18).  
Prolonged incubation of Ac1PIM2 with 
PimB' or PimA does not lead to further 
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extension of Ac1PIM2 (14). Instead, extending 
the mannosyl chain at the 6-OH requires a 
distinct set of mannosyltransferases. For 
instance, bioinformatical analysis of the genome 
of M. tuberculosis CDC1551 led to the 
identification of PimC, which catalyses 
synthesis of the trimannoside Ac3PIM3 (19). 
Still, the pimC deletion in Mycobacterium bovis 
bacille Calmette-Guérin (BCG) does not 
interrupt formation of higher PIMs, LM or 
LAM, for which PIMn=1-3 is considered a 
precursor, while genes orthologous to pimC 
were found in only 22% of clinical isolates. 
Thus, compensatory synthetic pathways must 
exist. Higher order PIM, LM, and LAM depend 
on glycosyl transfer from the lipid-saccharide 
donor C30/C50-P-Man and membrane-embedded 
glycosyltransferases, including PimE (20), with 
evidence for pathway bifurcation at Ac2PIM4 
(21, 22). 
The three-dimensional structures of soluble 
glycosyltransferases display only two 
fundamental fold topologies, termed GT-A and 
GT-B (23), contrasting with the diversity of 
protein folds among glycoside hydrolase 
enzymes (24). According to the sequence-based 
classification of carbohydrate-active enzymes, 
PimB' (Rv2188c) belongs to glycosyltransferase 
family 4 (GT4, http://www.cazy.org/GT4.html 
(25)). Encompassing a diverse range of 
enzymatic activities and substrate specificities, 
GT4 family enzymes assume the GT-B fold, 
with known structures for about half a dozen 
family members (26-30). The GT-B topology is 
characterized by two Rossmann fold-like 
domains, where donor and acceptor substrates 
bind in the central cleft between the two 
domains. In GT4 family transferases, the C-
terminal domain provides the majority of 
contacts for the nucleoside-diphosphate-
saccharide donor substrate, while the diverse 
acceptor-substrates bind to the more variable N-
terminal domain. A hinge region allows for 
conformational flexibility between the two 
domains, which can be dramatic, as is illustrated 
by the structures of ligand-free and substrate-
bound C. glutamicum MshA (PDB entries 3c48, 
3c4v (29)). Between these two states, the 
relative orientation of the domains changes by a 
97º rotational movement. Similar if less 
dramatic examples of inter-domain flexibility 
have been observed in structures of several other 
GT4 family members.   
Recently determined structures of GT4 
family enzymes includes that of M. smegmatis 
PimA, the enzyme catalysing transfer of the first 
mannosyl group to PI (27). This structure shed 
light on the mode of nucleotide binding and 
suggested a model for recognition of the 
acceptor substrate. While PimA and PimB' 
utilize the same donor substrate, their acceptor 
specificity is distinct. PimB' appears unable to 
mannosylate phosphatidyl-myo-inositol (or myo-
inositol-1-phosphate) on the 2-hydroxyl, while 
PimA does not mannosylate PI or PIM1 on the 
6-hydroxyl.  
In order to clarify structural differences 
between PimA and PimB' that could explain 
regio-selectivity we undertook the structure 
determination of PimB'. Attempts to generate 
recombinant protein of M. tuberculosis PimB' 
(Rv2188c) were unsuccessful, but 
overexpression of the C. glutamicum ortholog 
(NCgl2106) in Escherichia coli yielded soluble 
protein that crystallized when incubated with the 
donor substrate. Herein, we report the crystal 
structure of C. glutamicum PimB' in complex 
with nucleotide to a resolution of 2.0 Å, 
revealing flexibility of both the nucleotide 
conformation and the structural framework of 
the active site. The results of our site-directed 
mutational analysis are consistent with a 
substrate-mediated SNi (internal return) reaction 
mechanism, and indicate that a conserved 
aspartic acid in the acceptor-binding domain is 
critical in determining regio-selectivity of 
mannosyl transfer.  
EXPERIMENTAL PROCEDURES 
Recombinant protein production– Cloning 
of C. glutamicum PimB' has been described 
previously (15). Liquid cultures of E. coli BL21 
(DE3), harboring pET16b-pimB’, were grown at 
30ºC in LB-broth medium (Difco), 
supplemented with ampicillin (100 μg/mL). 
Expression of pimB’ was induced at OD600 0.4 – 
0.6 by adding 0.5 mM isopropyl--D-
thiogalactoside (IPTG). Cultures were incubated 
for a further 4 hours, before being harvested 
(4ºC, 4000g), washed with 0.85% saline and 
stored at –20 ºC.  For the expression of SeMet-
labeled PimB', liquid cultures were grown to 
OD600 0.4, then pelleted and resuspended in 1L 
minimal media twice (50 mM Na2HPO4, 20 mM 
KH2PO4, 10 mM NaCl, 20 mM NH4Cl, 20 mM 
MgSO4, 0.1 mM CaCl2 and 0.4% (w/v) 
glucose). Cells were grown at 37ºC to OD600 0.5, 
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then adding 100 mg L-lysine, L-phenylalanine 
and L-threonine, and 50 mg of isoleucine, 
leucine and valine, and 60 mg of L-seleno-
methionine. After 30 minutes at 37ºC, 
expression of pimB’ was induced adding 0.5 
mM IPTG, followed by incubation at 25ºC for 
24 hours. Cells were harvested and treated as 
before.  
Purification and crystallization– Cell 
pellets were thawed on ice and resuspended in 
30 mL of 50 mM NaH2PO4, pH 8, 300 mM 
NaCl and 10 mM imidazole (Buffer A), 
supplemented with an EDTA-free protease 
cocktail tablet (Roche). The suspension was 
sonicated (Sonicator Ultrasonic Liquid 
Processor XL, Misonix Inc.) on ice for a total 
time of 10 minutes, using 20-second pulses and 
40-second cooling periods. The lysate was 
centrifuged (27000g, 30 minutes, 4°C) and the 
supernatant passed through a Buffer A-
equilibrated Ni2+-charged His-Trap column (1 
mL, GE Healthcare). The column was 
subsequently washed with 50 mL of Buffer A 
with 20 mM imidazole, and the protein eluted 
with a 50-300 mM step gradient of imidazole. 
Fractions containing protein were dialyzed 
against 20 mM Tris-HCl pH 7.5, 10 mM NaCl, 
10% glycerol and 1 mM DTT. After dialysis, 
proteins were concentrated by ultrafiltration to 8 
mg/mL using a 10 kDa cut-off (Centriprep, 
Millipore). 
Prior to setting up crystallization trials, N-
terminally tagged PimB' was incubated 
overnight with 10 mM GDP-Man. Commercial 
sparse matrix screens (Molecular Dimensions) 
were used to identify crystallization conditions 
in hanging drop vapor diffusion experiments. 
Thin plate crystals formed at 6-26% PEG 3350, 
0.1 M Bis-Tris  pH 5.5, 0.1 M lithium sulfate 
and 0.1 M glycine. Crystals were cryoprotected 
by adding reservoir solution supplemented with 
8% w/v sucrose and 8% v/v glycerol to the 
crystallization drop with subsequent flash 
freezing in liquid nitrogen. Crystals of N-
terminally tagged PimB' were in space group 
P1, diffracting to 3.5 Å on the in-house X-ray 
source (Rigaku MicroMax 007HF, Saturn 944 
CCD), and to 2.2 Å at the synchrotron.  
Structure determination of triclinic crystal 
form– Single wavelength data of native C. 
glutamicum PimB' were recorded on beamline 
ID29 at ESRF, Grenoble, France (Table 1) at 
10% transmission. Analysis of the Matthews 
volume suggested the presence of two molecules 
of PimB' per asymmetric unit (VM = 2.28 Da/Å
3) 
with a predicted solvent fraction of 47%.  Initial 
attempts to phase by molecular replacement 
(MR) resulted in a statistically significant 
solution in terms of the PHASER Z-score (Z = 
9.0, resolution range 10 - 3Å) (31), but failed to 
yield a useful electron density map.  As the thin 
plate crystals did not tolerate soaking in heavy 
metal salts, we generated SeMet-derivatized 
crystals of PimB' and recorded data at the Se-K 
edge (Table 1). Significant radiation damage of 
the cryogenically cooled crystals limited data 
acquisition to the peak wavelength, and due to 
the triclinic symmetry, resulted in data of low 
multiplicity (Table 1). In order to optimize the 
anomalous signal and completeness of Bijvoet 
pairs an inverse beam protocol was used, 
recording data in sets of 20 successive frames 
(0.5º oscillation) at  and  + 180º, respectively. 
Data were reduced using XDS and XSCALE 
(32). Only one of several SeMet SAD data sets 
(SeMet1 in Table 1) recorded from a series of 
crystals provided a sufficiently strong 
anomalous signal to extract the Se positions 
using SHELXD (33). Patterson self-rotation 
maps indicated a non-crystallographic (NCS) 2-
fold rotation axis parallel to the b-axis, 
consistent with the assumption of two molecules 
per asymmetric unit. Therefore, Se-positions 
obtained in runs of SHELXD were analyzed 
with PROFESSS (34) to derive the NCS 
operator and to verify that this operator was 
consistent with the self-rotation function. An 
initial set of 10 Se positions (5 per molecule) 
could be identified this way. SAD phasing in 
SHARP (35) allowed us to establish an 
additional set of 8 positions through difference 
Fourier analysis. Thus, 18 of 20 possible Se 
positions were obtained, but were not sufficient 
to obtain an interpretable map, either in SAD 
phasing using the best SeMet data or in phasing 
by MIR using the best SeMet together with the 
native data.  
Next, we co-crystallized PimB' (N-
terminally tagged) with a brominated derivative 
of GDP-Man, the synthesis of which has been 
described in (36). Combining the PimB' native 
data with this brominated derivative and the best 
four SeMet data sets led to a density map with 
recognizable secondary structure features 
(supplemental Fig. 2SA), albeit still too poor to 
build. Two-fold NCS averaging and phase 
extension to nominally 2.2 Å distinctly 
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improved the map (Supplemental Fig. 2SB). In 
order to support map interpretation we 
reconciled the previously established MR 
solution with the experimentally determined set 
of Se positions. This was aided by generating a 
homology model of the C-terminal domain of 
PimB' (using MODELLER (37)), which 
reproduced a subset of distance vectors between 
Se positions. Superimposing the homology 
model onto the experimental map aided 
interpretation of poorly defined areas, greatly 
accelerating model building. Iterative rounds of 
model building and minimization in REFMAC5 
(38) very quickly led to a high quality 2Fo – Fc 
map (supplemental Fig. 2SC) that revealed 
previously undefined parts of the structure.  The 
final model describes residues 4 to 381 of the 
PimB'  (381 residues), with excellent 
stereochemistry (Table 1).  
In both molecules of the triclinic crystals, 
the active site contains weak density for GDP-
Man. Therefore, the ligand was omitted from the 
model until the structure refinement had 
converged to Rcryst/Rfree values of 19.1%/22.4%. 
Adding GDP to this late-stage model, at full 
occupancy, reduced Rfree marginally, giving 
rise to negative difference density. Systematic 
variation of the occupancy of GDP between 0.5 
and 1 resulted in a flat difference map around 
the ligand for 0.75. At this occupancy, the B-
factors of the ligand atoms refined to an average 
of 31 Å2, compared to a protein average of 12.5 
Å2 and an overall Wilson B-factor of 19.3 Å2.  
While density for the mannose moiety is visible 
(Fig. 4A), it is insufficient to fit the saccharide 
unequivocally. 
Structure determination of the 
orthorhombic crystal form– C-terminally tagged 
PimB' (8 mg/ml) was incubated overnight with 
either GDP or GDP-Man (20 mM) prior to 
setting up vapor diffusion experiments. Crystals 
of sufficient size appeared over reservoirs 
containing 0.1 M DL-malic acid pH 6.1, 13% 
PEG 3350 (GDP-Man complex) or 0.1 M 
sodium citrate pH 5.1, 22% PEG 3350 (GDP 
complex). Crystals were cryoprotected in 
mother liquor supplemented with 8% w/v 
sucrose and 8% glycerol and frozen in liquid 
nitrogen. The structure of the orthorhombic 
crystal form of PimB' was solved by MR, using 
a monomer of the refined 'triclinic' structure as 
search model in PHASER (31). The structural 
models were rebuilt in COOT and refined using 
REFMAC5 (38). Figures 2 – 5 were prepared 
using PyMOL (www.pymol.org). 
Preparation of polar lipids and Ac1PIM1– 
Polar lipids containing Ac1PIM1 were extracted 
from C. glutamicum-pimB’mgtA as described 
previously (15, 39).  The lipid extract was 
examined by 2-dimensional thin layer 
chromatography (TLC) on aluminum-backed 
plates of silica gel 60 F254 (Merck 5554), using 
CHCl3/CH3OH/H2O (60:30:6, v/v/v) in the first 
direction and CHCl3/CH3COOH/CH3OH/H2O 
(40:25:3:6, v/v/v/v) in the second direction. The 
glycolipids were visualized by spraying plates 
with either -naphthol/sulfuric acid, Dittmer & 
Lester Reagent, or 5% ethanolic 
molybdophosphoric acid followed by gentle 
charring of plates. Glycolipids were further 
separated into individual PIMs and other 
glycolipid species by preparative TLC on 10 cm 
 20 cm plastic backed TLC plates of silica gel 
60 F254 (Merck 5554), run in 
chloroform/methanol/water (60:30:6, v/v/v). 
The plates were then sprayed with 0.01% 1,6-
diphenyl-1,3,5-hexatriene dissolved in 
petroleum ether/acetone (9:1 v/v) and the 
glycolipids were visualized under UV light. 
Following detection the plates were re-
developed in toluene to remove diphenyl-1,3,5-
hexatriene and the corresponding glycolipid 
bands were scraped from the plates and 
extracted from the silica gel using 
chloroform/methanol (2:1, v/v). Samples were 
analyzed by MALDI-TOF-MS as described 
previously (17). 
Activity assay– PimB’ was assayed for 
mannosyltransferase activity using a method 
adapted from (40). 20 g of PimB’ was 
incubated with either purified Ac1PIM1 (4 - 200 
g) or polar lipids (100 g) extracted from C. 
glutamicum-pimB’mgtA, in the presence of 
0.5 μCi GDP-[14C]mannose (GE Healthcare), 
0.125 mM ATP, 1 mM NADP, 10 mM CaCl2, 
0.1% (v/v) IGEPAL (Sigma) and 20 mM Tris-
HCl pH 7.5 in a total volume of 100 μL. The 
reaction was incubated at 37°C for 30 minutes 
and quenched with the addition of 
CHCl3:MeOH:H2O (10:10:3). Unincorporated 
GDP-[14C]mannose was removed by the 
addition of 2.625 mL of CHCl3 and 1.125 mL of 
H2O, followed by centrifugation to separate the 
organic and aqueous layers. The lower organic 
layer was washed three times with 3 mL of 
CHCl3:MeOH:H2O (3:47:48) and dried. 
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Incorporation of GDP-[14C]mannose in the 
acceptor was measured using a scintillation 
counter and samples were analyzed by TLC run 
in CHCl3:MeOH:H2O:NH4OH (65:25:3.6:0.5). 
Trp fluorescence binding assay– Binding of 
GDP and GDP-Man was measured using 
intrinsic tryptophan fluorescence. The sample 
was excited at a wavelength of 295 nm and the 
resulting fluorescence emission was measured 
between 300 and 400 nm (scan speed 100 
nm/min) using a Photon Technology 
International fluorescence spectrometer. Spectra 
were recorded for each addition of GDP-Man or 
GDP, to 700 μL of a 2 M solution of PimB’. 
The experiment was repeated in triplicate and 
fluorescence intensity at 330 nm was plotted 
against ligand concentration and fitted to a one-
site saturation binding model using 
SIGMAPLOT (Systat). In order to compensate 
for inner filtering of the ligand, we monitored 
fluorescence of albumin at a range of GDP 
concentrations, and derived a concentration-
dependent correction to the Trp-fluorescence 
signal.  
Docking of PIM1– A molecular model of 
PIM1 was manually docked into the active site 
of PimB' (closed configuration) guided by the 
following considerations: i) no steric clashes 
must occur and no adjustments to the protein 
structure should be necessary; ii) the 6-hydroxyl 
of inositol should be presented to C1 of the 
donor saccharide, while minimizing the oxygen-
carbon distance; iii) if possible, inositol 
hydroxyls should form H-bond contacts with 
nearby H-bond acceptors; iv) while bound to the 
enzyme, the acyl chains attached to the glycerol 
backbone of the acceptor should be free to insert 
into the cell membrane. The validity of the 
resulting model of the ternary complex was 
tested by mutagenesis. 
RESULTS 
Structure determination. Crystals of C. 
glutamicum PimB' were grown in two crystal 
forms with triclinic and orthorhombic lattices, 
depending on whether the recombinant protein 
carried a His6-affinity tag at the N- or C-
terminus, respectively. Incubation of N-
terminally tagged PimB' with the native donor 
substrate guanosine-5'-diphosphate--D-
mannopyranose (GDP-Man, 10 mM) produced 
triclinic crystals, based on which the structure 
was determined (see Experimental Procedures, 
supplemental Fig. 2S). The refined 'triclinic' 
model (2.2 Å resolution, Fig. 2A, Table 1) 
comprises two molecules of PimB' (residues 4 – 
381) in the asymmetric unit, missing only the 
first three residues of C. glutamicum PimB'. The 
two copies were refined applying tight NCS-
restraints (root mean square deviation (RMSD) 
between 378 C pairs of 0.03 Å, estimated 
coordinate error 0.37 Å, Table 1).  Subsequent 
to the structure determination, an orthorhombic 
crystal form was obtained and refined to a 
resolution of 2.0 Å. The lattices of the 
orthorhombic and triclinic crystal forms are 
similar (triclinic at = 44 Å, bt = 50 Å, ct = 85 Å; 
      90º; orthorhombic: ao = at, bo = ct, co 
 2 bt, Table 1), but show distinct packing 
interfaces. This is presumably due to the affinity 
tag, which is disordered in the orthorhombic 
lattice, but partially ordered in the triclinic 
crystal form. Weak density for GDP-Man was 
observed in both copies of PimB' in the 'triclinic' 
model, suggesting partial occupancy. In 
contrast, the GDP- and GDP-Man-bound 
structures of the orthorhombic form show strong 
density for the nucleotide, although the mannose 
moiety is disordered (see below).  
Overall structure of PimB'. The structure of 
C. glutamicum PimB' displays the canonical fold 
of GT-B glycosyltransferases, comprising two 
Rossmann fold-like domains (41) that are 
connected by a hinge region with the substrate 
binding sites located in the cleft between the 
domains (Fig. 2A). The N-terminal domain 
(residues 4 – 171, 364 – 381), assumed to bind 
the acceptor substrate, is composed of a 7-
stranded, parallel -sheet (strands 1 - 7), with 
connecting helices 1 to 6. The C-terminal 
domain (residues 172 – 363) binds the 
nucleotide-sugar donor substrate, and consists of 
a 6-stranded, parallel -sheet (strands 8 - 13) 
with connecting helices 8 to 11, and 3106. A 
conserved feature of GT4 family enzymes, and 
indeed of the GT-B fold, are the consecutive C-
terminal helices 13 and 14 that span the 
length of the protein and belong to the C- and N-
terminal domains, respectively. Domain 
reorientation is facilitated by a flexible hinge 
between the domains, consisting of the 7-7 
loop, with invariant Gly171 at its centre, and the 
short linker separating helices 13 and 14, 
with highly conserved Trp365 clamped between 
the domains (Fig. 2A, supplemental Fig. 1S). 
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Differences in crystal packing between the 
orthorhombic and triclinic crystal forms resulted 
in a slightly different inter-domain orientation 
(4º rotation), and an additional helix, 5' 
(residues 120 – 125), in the active site cleft (Fig. 
3A). In the domain-wise superposition, the 
triclinic and orthorhombic models match closely 
(RMSD of 1.27 Å for N-terminal domain, 0.39 
Å for the C-terminal domain), but individual 
residues in the region of helix 5' undergo 
considerable shifts of their position. For 
instance, the -carbon of Trp124 is shifted by 7 
Å, and its side chain switches from contacts 
with the C-terminal domain (Gly285, Leu287 of 
the 11-11 loop) to folding back onto the N-
terminal domain in the orthorhombic form.  
Structural neighbors. We searched for 
structural homologs of PimB' in the PDB 
through distance matrix alignment (DALI, (42)). 
The closest neighbor with respect to overall 
structure was glycosyltransferase MshA from C. 
glutamicum  (Fig. 2B, PDB entry 3c48, Z  = 
23.7, RMSD 1.6 Å, 180 aligned C pairs of 393 
residues, sequence identity 31%) (29), followed 
by glycosyltransferases E. coli WaaG (2iw1, Z 
21.8, 2.3 Å, 180/370 C pairs, 25% id.) (26), 
and Bacillus anthracis  Ba1558 (2jjm, Z 21.3, 
1.8 Å, 177/359 C pairs, 21% id.) (28). The 
fourth hit was the functionally related -
mannosyltransferase M. smegmatis PimA (Fig. 
2C, 2gej, Z 20.1, 1.9 Å 176/361 C pairs, 24% 
id.). Restricting the DALI search to the more 
variable N-terminal domain, which commonly 
binds the acceptor substrate, the closest 
neighbor was the N-terminal domain of B. 
anthracis Ba1558 (2jjm, Z 19.2, 2.1 Å, 165 C, 
18% id), followed by those of MshA (3c48, Z 
16, 2.6 Å, 172 C, 10% id.) and PimA (2gej, Z 
15.4, 161 C, 17% id.). 
The structural comparison between PimB' 
and PimA (Fig. 2C) is of particular interest as 
they catalyze subsequent steps in PIM 
biosynthesis utilizing identical saccharide 
donors (GDP-Man), yet showing distinct regio-
selectivity for mannosylation of the inositol 
moiety of PI. The domain-wise superposition of 
PimB' and PimA shows conserved cores for 
either domain (N-terminal domain: RMSD 1.53 
Å for 106 C pairs; C-terminal domain: RMSD 
1.19 Å for 147 C pairs). Yet, several structural 
differences are noteworthy. First, PimB' lacks 
the extended 3-3 loop, due to a 10-residue 
deletion (supplemental Fig. 1S). This loop, 
referred to as 'IP-binding' loop (10, 29), has 
been implicated in acceptor substrate binding in 
both PimA and MshA. While fully ordered in 
PimB', it is disordered in nucleotide-bound 
PimA (Fig. 2C). Second, the 11-11 loop in 
PimB' has a 6-residue insertion relative to PimA. 
This loop makes contacts with the structurally 
variable loop 5–5 (containing helix 5' in 
orthorhombic PimB'). Furthermore, PimB' 
comprises additional helices in the N-terminal 
(2) and C-terminal domains (7, Fig. 2C), 
while helix 5 of PimB' overlaps partially with 
helices 4 and 5 in PimA.  
 Active site and nucleotide binding. We 
crystallized PimB' in the presence of GDP or 
GDP-Man, which bind with affinities in the 
order of 20 – 40 μM in terms of Kd (Table 2). 
Density for the nucleotide is weak in the triclinic 
crystal form (10 mM GDP-Man present during 
crystallization, Fig. 4A), but is well defined for 
the orthorhombic crystals (20 mM GDP or 
GDP-Man, Fig. 4B and C). The nucleotide 
binding site is situated in the cleft between N- 
and C-terminal domains of PimB' (Fig. 3B), a 
conserved feature of GT-B glycosyltransferases. 
In all cases, binding of the nucleotide (GDP or 
GDP-Man) resulted in crystallization of an 
'open' configuration of PimB', in marked 
contrast to the donor substrate-bound structures 
of PimA and MshA (supplemental Fig. 3S). In 
this configuration, the central cleft is open and 
the nucleotide makes no contacts with residues 
in the N-terminal domain. A small, but 
significant density blob in triclinic PimB' 
indicates the presence of mannose (Fig. 4A), but 
the blob fails to define the conformation of the 
saccharide moiety unequivocally. Paradoxically, 
the mannose moiety is disordered in the 
orthorhombic crystals of GDP-Man-bound 
PimB' (Fig. 4B), although the ligand density is 
much stronger overall. We attribute the absence 
of mannose density to the absence of stabilizing 
contacts in the open form of the enzyme. We 
found no indication of mannose-release in the 
absence of acceptor substrate when incubating 
PimB' with [14C]-labeled GDP-Man over a 
period of several hours.  
 With few exceptions, residues in contact 
with the nucleotide reside in the following 
structural elements: the 8-8 loop, the 10-
10 loop and the 11-11 loop (Fig. 3B). The 
purine base forms hydrogen bonds with the 
amide nitrogen and carbonyl groups of Leu261 
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(10-10 loop), but no specificity determining 
contacts with side chain atoms. The side chains 
of Val235 (C-terminal end of 9), Arg260 and 
Met266 (10-10 loop), contact the base by 
way of apolar and van der Waals contacts. 
Interestingly, in the (low-occupancy) 'triclinic' 
structure, Arg260 is only partially ordered. The 
C2' and C3' hydroxyls of the ribose make 
conserved H-bond interactions with the side 
chain carboxyl of Glu298 (helix 11). The 
pyrophosphate group is set against a surface of 
positive electrostatic potential of residues 
Arg206, Arg210 and Lys211 (8-8 loop), and 
the 'oxyanion hole'-like surface of four 
consecutive amide nitrogen groups (residues 
291 to 294) in the 11-11 loop. The 
carboxylate group of Glu290, a highly 
conserved residue in the 11-11 loop, is held 
in a fixed orientation through ionic bonds with 
Lys211 and Arg210, neutralizing its negative 
charge that would otherwise repel the close-by 
-phosphate (d ~ 3.8 Å). 
It was surprising to find the pyrophosphate 
in two distinct conformations that differ with 
respect to the position of the -phosphate, 
whereas the position of the -phosphate is more 
or less fixed, stabilized by ionic contacts with 
the guanido group of Arg206 and the terminal 
ammonium group Lys211 (Fig. 3B and 4). 
Recording diffraction data of three independent 
GDP-bound complexes, the pyrophosphate of 
GDP consistently displayed a conformation that 
coincides with that seen in the UDP-bound 
complex of trehalose-6-phosphate synthase (E. 
coli OtsA, PDB entries 1uqu, 2wtx (43-45)). In 
this 'OtsA-like' conformation, the -phosphate is 
positioned close to the main chain amide 
nitrogen groups of Ile294 and Val295 (N-
terminal of helix 11), forming weak H-bonds 
(3.3 to 3.5 Å) (Fig. 4C). In contrast, 
orthorhombic crystals of PimB' in complex with 
GDP-Man show a superposition of the 'OtsA-
like' conformer and a second conformation that 
resembles the nucleotide conformation in GDP-
Man-bound PimA (Fig. 4B) (2gek, 2gej) (27). In 
the PimA-like conformation, the -phosphate is 
positioned within H-bond distance (2.9 Å) of N 
of Arg206. The conversion between the OtsA- 
and PimA-like conformers occurs through a 
rotation of approximately ~120º about the C4'-
C5' bond of the ribose, drastically altering the 
position of the -phosphate and shifting the -
phosphate by about 0.5 – 0.6 Å away from 
Arg206, while the guanosine moiety remains 
stationary. Interestingly, the triclinic crystal 
form shows density only for the PimA-like 
conformer (Fig. 4A).  
 Modeling the ternary complex. In order to 
understand the structural basis of regio-
selectivity of mannosyl transfer, we modeled the 
closed configuration of PimB', as this is 
assumed to represent the catalytically competent 
conformation. Attempts to crystallize ternary 
complexes of PimB' bound to GDP and acceptor 
substrate analogs were not successful. Crystals 
formed readily when (C-terminally tagged) 
PimB' was incubated with excess amounts of 
GDP and of either D-myo-inositol-1-phosphate 
or deacylated PIM1. Nonetheless, the diffraction 
data consistently revealed density for the 
nucleotide, but none for the acceptor. Binding 
studies for PimA (27) and kinetic studies of 
MshA (46) showed that the substrates bind 
sequentially, with the sugar-nucleotide binding 
first, followed by the acceptor. This scenario 
very likely applies to PimB' as well, and 
acceptor binding may require the 'closed' 
configuration, which, in the case of PimB', 
appears to be disfavored in crystal lattice 
formation. 
 The model of the closed form of the 
enzyme was constructed using the template of 
the ternary complex of C. glutamicum MshA 
(PDB entry 3c4v), the closest structural 
neighbor of PimB' according to our DALI 
search. The structures of PimB' (orthorhombic 
form) and MshA were aligned by secondary 
structure matching with respect to their C-
terminal domains, followed by aligning the N-
terminal domain of PimB' to the N-terminal 
domain of MshA, which involves a 27º-rotation 
(Fig. 5A). The rigid body rotary movement of 
the N-terminal domain towards the C-terminal 
domain leads to minor steric clashes between 
helix 5' and the 11-11 loop. However, as the 
comparison between the 'triclinic' and 
'orthorhombic' structures of PimB' has 
demonstrated, the 5' region is conformationally 
flexible. Therefore, it is justified to assume that 
this region will adapt to spatial constraints 
imposed by the rotary movement.  
 As density for the mannose moiety was not 
sufficiently defined, we modeled its orientation 
according to the nucleotide-on-nucleotide 
superposition of PimB' with the UDP-glucose 
bound structure of OtsA. The latter complex 
 at The University of Birm
ingham
, on February 11, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
  8 
structure in conjunction with the ternary 
complex of OtsA bound to UDP and a 
disaccharide mimetic inhibitor has provided the 
most compelling structural evidence as yet to 
support the proposed SNi internal return 
mechanism for retaining glycosyltransferases of 
the GT-B fold (see Discussion) (24, 43-45).   
Despite restricting the protein modeling to 
a rigid body motion of the N-terminal domain 
and positioning the mannose moiety of GDP-
Man according to a structural superposition 
between enzymes that share only 15% sequence 
identity, the resulting structural model displays a 
number of mechanistically plausible features. 
First, the rotary motion places residue Ile18, 
which precedes the Gly-Gly motif, on the face 
of the guanosine base, analogous to the 
interaction of the corresponding residues in 
PimA (Pro), and OtsA (Ala) (Fig. 5B). The 
resulting closed binding cavity for the sugar-
nucleotide can accommodate GDP-Man without 
steric overlap. The binding cavity also allows 
the nucleotide to adopt both conformations that 
we observed for the pyrophosphate. Importantly, 
the binding cavity shows a prominent opening, 
which selectively exposes the C2 hydroxyl and 
the C1 carbon of GDP-mannose to the putative 
acceptor-binding site (Fig. 5B).   
We manually docked a model of PIM1 (2-
mannosyl-phosphatidyl-myo-inositol-1-
phosphate) into the cleft of the 'closed' enzyme 
(shown in cyan in Fig. 5), such that the 6-
hydroxyl is pointing towards the exposed 
mannose moiety, while the mannosylated C2 is 
pointing in the opposite direction. In this way, 
the 3- and 4-OH groups of the inositol ring are 
positioned within H-bonding distance to the 
carboxylate of Asp13 in the 1-1 loop, 
providing a bidentate anchoring interaction that 
defines the orientation of the inositol ring. In 
PimA, the residue corresponding to Asp13 is 
Tyr9, which has been previously implicated in 
acceptor substrate specificity of mannosyl 
transfer (10, 14, 27). The phosphate moiety is 
positioned within 3.5 Å of the guanido group of 
Arg210, suggesting that Arg210 might 
contribute to acceptor recognition. We also note 
that in this model, the position of the phosphate 
moiety falls in close range of an ordered sulfate 
molecule of the triclinic structure, which is 
coordinated by Arg206 (Fig. 3B). The model of 
the closed complex then served as a guide to 
probe the structural determinants of acceptor 
binding by site-directed mutagenesis.  
Mutagenesis. In order to assess the 
significance of selected residues for PimB' 
function, we probed enzyme activity by 
monitoring the transfer of [14C]-labeled mannose 
from GDP-Man to Ac1PIM1 (Fig. 6A, Table 2). 
Products were analyzed in terms of radioactivity 
and by thin layer chromatography (Fig. 6A), 
while nucleotide binding was assayed by 
intrinsic tryptophan fluorescence (Fig. 6B). In 
addition, proper folding of mutants was 
ascertained by circular dichroism spectroscopy 
(Fig. 6C and  supplemental Fig. 4S). 
Residues of the C-terminal domain that 
contact the nucleotide, very sensitively influence 
enzymatic activity.  Residual activity of single-
residue mutants of the three basic side chains 
(Arg206, Arg210 and Lys211) situated in the 
vicinity of the pyrophosphate is less than 9% 
that of wild-type (Fig. 3B, Table 2). Likewise, 
mutation of the conserved Glu residue at 
position 290 to either Gln or Asp reduced 
activity by more than 95% (Fig. 6A, Table 2). 
While detrimental for activity, all of these 
mutants still bind the acceptor substrate with 
appreciable affinity. Thus, these mutations 
generally weaken, but do not abrogate binding 
of GDP or GDP-Man.  
While the nucleotide binding site is highly 
conserved between PimA and PimB', subtle 
structural differences are evident. For instance, 
Gly291 in PimB' corresponds to a serine in 
PimA. Modeling the GDP-Man in PimB' 
according to the PimA:GDP-Man complex 
indicated potential steric hindrance between a 
serine on position 291 and the mannose moiety. 
Indeed, compared to wild-type PimB', the 
G291S mutant shows 95% reduced activity, and 
a nearly 4-fold increase in Kd for binding of 
GDP-Man (Table 2). In contrast, the substitution 
of Ser205 with the corresponding Gly in PimA 
increases activity by about 10%, although the 
increase is within one standard deviation.  
DISCUSSION 
PIM biosynthesis occurs through a series of 
enzyme-catalyzed reactions during which PI is 
decorated on the inositol moiety with mannosyl 
groups in an ordered and regio-selective 
manner. The present structure in combination 
with the mutational analysis sheds light on how 
regio-selectivity is achieved and provides 
indirect evidence for the hypothesis that 
 at The University of Birm
ingham
, on February 11, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
  9 
catalysis occurs through a substrate-mediated 
SNi internal return mechanism. 
In terms of fold and overall structure, 
PimB' conforms to the paradigm of GT-B 
glycosyltransferases. However, a couple of 
observations are noteworthy. First, nucleotide 
binding did not result in crystallization of a 
closed configuration of the enzyme, in contrast 
to the closed states observed for the nucleotide-
bound complexes of PimA, MshA, OtsA or 
WaaG (26, 27, 29, 45). However, it seems 
improbable that PimB' is unable to close the 
active site cleft, given the close similarity to the 
structural homologs. Small changes in 
orientation of the domains between the 
orthorhombic and triclinic crystal form, provide 
direct evidence for conformational flexibility. 
More importantly, the G20W mutation leads to 
97% drop in activity, but binds the donor with 
affinity similar to that of wild type PimB' (Table 
2). The fact that a bulky side chain in the centre 
of the cleft is tolerated in terms of nucleotide 
binding, but abrogates activity is consistent with 
the notion that it impedes the closing motion.  
Second, the conformational flexibility 
observed in the 5-5 loop of the active site 
cleft has not been observed previously in GT4 
glycosyltransferases. The shift of individual side 
chains and the corresponding change of 
intramolecular contacts seems significant. For 
instance, the position of Trp124's C is shifted 
by 7 Å, and its side chain makes contacts with 
different parts of the structure in the two crystal 
forms. We probed whether helix 5' is required 
for activity by substituting glycine at position 
123 with proline, but the resulting drop of 
activity is only about 15% (Table 2). 
Furthermore, His120 at the N-terminus of helix 
5' is only ordered in the triclinic structure and 
disordered when helix 5' forms. Substituting 
His120 by serine reduced activity by about 20% 
(Table 2), while the CD spectrum of the mutant 
G123P is virtually identical to that of wild-type 
PimB' (supplemental Fig. 4S). In light of this 
data, we hypothesize that the conformational 
flexibility of the 5-5 loop works in concert 
with the open/closing motion of the active site 
cleft upon substrate binding, but influences 
catalysis only in an indirect fashion, if at all. 
PimB' is a GT-B glycosyltransferase that 
retains the stereochemical configuration of the 
anomeric carbon of the donor saccharide. The 
catalytic reaction mechanism of retaining GT-B 
transferases has remained somewhat of a 
mystery. In glycoside hydrolases, retention of 
the anomeric configuration occurs through an 
SN2-like double displacement mechanism, 
mediated by a pair of side chain carboxylates 
and involving a covalent sugar-enzyme 
intermediate (47). However, none of the 
inhibitor- or substrate mimic-bound complexes 
solved to date has provided structural evidence 
to support such a scenario in GT-B 
glycosyltransferases (24, 48-50). Instead, a 
substrate-mediated SNi (internal return) 
mechanism has been invoked, reviewed in 
reference (24). This mechanism involves three 
tightly linked reaction steps (Scheme 1): first, 
decay of the sugar-phosphate bond, leaving a 
(solvent-separated) ion pair of the oxocarbenium 
ion-like saccharide and the negatively charged 
phosphate (panels 2,3); second, deprotonation of 
the acceptor hydroxyl by the phosphate leaving 
group; third, nucleophilic attack by the acceptor 
on the oxocarbenium ion (panels 3,4). The first 
step is rate limiting, while the subsequent steps 
must occur on a time scale shorter than solvent 
attack or ion pair re-organization (24). If correct, 
this mechanism imposes constraints on the 
geometry of donor and acceptor substrate in the 
ternary complex, in that the leaving group must 
be sufficiently close to the acceptor to be able to 
deprotonate the attacking acceptor hydroxyl.   
In our model of the acceptor-bound 
complex, the 6-OH of inositol (Oi6) is 
positioned within ~ 4 Å of the C1 carbon of the 
donor mannose, and within 5 Å of the -
phosphate (P). The distance vectors Oi6–C1 
and C1–P enclose an angle of ~ 105º. Thus, the 
geometric configurations of the substrates in the 
ternary complex model are compatible with the 
requirements of the SNi reaction mechanism. 
Our mutagenesis data provide further supporting 
evidence for a substrate-dependent reaction 
mechanism. For instance, the most obvious 
candidate to act as catalytic nucleophile in an 
SN2-like mechanism is Glu290, a carboxylate 
that is strictly conserved across GT4 family 
enzymes, and positioned close (~ 4.5 Å) to the 
sugar-phosphate bond. Switching this residue to 
glutamine, which should completely impair 
nucleophilic attack, decreases activity by about 
95%, while leaving substrate binding largely 
intact (< 3-fold increase of Kd). Importantly, the 
residual activity is about 10 times above 
baseline level, and can be reduced further by the 
E290D substitution (Table 2).  In contrast, the 
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substitution of highly conserved His118 by 
serine decreases activity essentially to baseline 
level. In the 'open' configuration, H118 does not 
contact the donor substrate, but in the 'closed' 
model contacts the C6 hydroxyl of the 
nucleotide-linked mannose. His118 is positioned 
closely opposite to Ile21 (closest contact 3.9 Å). 
Substitution of Ile21 with either Ser or Ala 
diminishes activity to about 2.5%. The close 
proximity of a hydrophobic side chain to His118 
suggests that the latter is pushed to its non-
ionized state, which could enable the His side 
chain to act as a nucleophile. However, in our 
modeled ternary complex as in the experimental 
structures of OtsA (2wtx) or MshA (3c4v), the 
position of His118 relative to the nucleotide 
makes such a role improbable. 
In their structural evaluation of PimA, 
Guerin and colleagues (27) identified Tyr9 as a 
residue that might form a stacking interaction 
with the inositol ring of PI, and thus may be key 
to acceptor specificity. This tyrosine is located 
in the 1-1 loop and corresponds to Asp13 in 
PimB'. Within the sequences of PimB' and 
PimA enzymes, respectively, the Asp and Tyr 
are strictly conserved at this position 
(supplemental Fig. 1S). In the model of the 
ternary complex, Asp13 is positioned within H-
bond distance to the 3- and 4-OH of the inositol 
moiety, i.e. the only inositol hydroxyls that are 
in an equatorial configuration. Such a bidentate 
interaction would ensure that inositol presents 
the axial 6-OH, rather than the 2-OH to the C1 
carbon of mannose. Indeed, swapping the 
positions of 3-OH and 4-OH of inositol would 
present the 5-OH to C1 of mannose, rather than 
2-OH. Probing Asp13 by mutagenesis, it is 
intriguing that even the most conservative 
substitution - aspartate to asparagine - reduces 
activity by 98.5% relative to wild type. Indeed, 
this subtle change knocks down activity as 
effectively as the more drastic Asp to Ala 
substitution (Table 2). Residues in the 
immediate vicinity – Asn12, Ile21 and Gln22 – 
are similarly sensitive to substitutions, causing a 
reduction of activity by at least 70%. We also 
probed whether the specificity of PimB' can be 
switched to mannosylation of the 2-OH by 
substituting Asp13 by tyrosine. However, the 
result was a knock-down of activity to blank 
level (Table 2). Thus, residues in the 1-1 loop 
play a key role in acceptor recognition, but the 
single substitution on position 13 is not 
sufficient to switch acceptor specificity. 
The deleterious effect of the D13N 
mutation stresses the significance of Asp13 in 
determining acceptor specificity, although the 
mechanistic implication of this substitution is 
not clear, as an asparagine should still be able to 
form H-bonds with the inositol hydroxyl groups. 
However, the effect is reminiscent of an 
analogous mutation in glycosidase family 
GH68. There, substitution of a strictly conserved 
Asp by Asn, which formed strong H-bonds with 
saccharide substrate hydroxyls, but, for 
geometric reasons, could not be a nucleophile or 
general acid/base, reduced activity by 2 orders 
of magnitude in terms of kcat. This effect was 
attributed to stabilization of the oxocarbenium 
ion transition state by the negatively charged 
carboxylate (51, 52). Lack of sequence 
conservation across GT4 family enzymes 
appears to rule out a fundamental role of Asp13 
in a general reaction mechanism of GT4 
enzymes. However, we note that PimA extends 
a glutamic acid side chain (residue 199) towards 
the inositol ring when superimposed with our 
model of the PimB' ternary complex. This 
glutamic acid, which is critical for activity (10), 
is located in the 8-8 loop, and, in the 
structural superposition, lines up with Val208 of 
PimB'. Our model suggests that Glu199 could 
form H-bond contacts with the equatorial OH 
groups of inositol, if the inositol moiety is 
oriented such that the 2-OH is presented to the 
C1 of the donor saccharide. Thus, the active site 
cleft of PimA includes a side chain that could 
play a role functionally analogous to that of 
Asp13 in PimB'.  
The dual conformation of the 
pyrophosphate in complexes co-crystallized 
with GDP-Man is intriguing. This feature could 
be mechanistically linked to release of the donor 
mannosyl group following decay of the sugar-
phosphate bond and transfer to inositol. 
PimB':GDP complexes have a pronounced 
preference for the 'OtsA'-like nucleotide 
conformation, while GDP-Man bound PimB' 
either displayed the superposition of the OtsA- 
and PimA-like states or only the PimA-like 
state. Density for the mannose group is 
completely missing in the orthorhombic 
complex. Yet the presence of a disordered sugar 
moiety can be inferred on the one hand from the 
pronounced preference for a dual nucleotide 
conformation in the GDP-Man co-crystals and, 
secondly, from the positioning of an extra water 
molecule between -phosphate and Glu290 in 
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the GDP co-crystals (W4, Fig. 4C). These 
observations were consistent between at least 
two different crystals of each complex. Between 
the PimA- and OtsA-like conformations, the -
phosphate shifts away from Arg206 by about 
0.5-0.6 Å, weakening the corresponding ionic 
interaction, which would facilitate increased 
mobility of Arg206. Such increased mobility of 
this side chain could promote release of the 
transferred mannosyl group from the confines of 
the donor substrate-binding cavity.  
Concluding remarks. Biosynthesis of PIM 
occurs through a series of glycosyltransfer 
reactions that initially take place at the 
cytoplasmic side of the membrane. The final 
product is presented on the extracellular face of 
the membrane, and hence flippase-mediated 
membrane translocation of either the final or an 
intermediate product must occur along the way 
(3). We consider the following scenario 
probable: PimA, PimB' and PimC act on 
acceptor substrates - PI and intermediate forms 
of PIM - that are anchored in the cytoplasmic 
leaflet of the membrane. The active site 
geometry of PimB' and its electrostatic surface 
potential (supplemental Fig. 5S) are compatible 
with the notion of transient membrane 
association, potentially in the orientation shown 
in Fig. 5A. Liposome binding data recorded for 
PimA further support this scenario (27).  PimB' 
differs from PimA in several structural details 
that reflect their distinct acceptor substrate 
specificities. Chief among them is the lack of 
the extended 3-3 loop, which contributes to 
acceptor binding in PimA, but, based on 
geometry, cannot play such a role in PimB'. 
Second, the active site cleft shows a more open 
surface, to accommodate the mannose attached 
to the 2-position of inositol. Third, we show that 
Asp13, which is critical for activity, cannot be 
swapped for the corresponding tyrosine in 
PimA. We postulate that Asp13 is chiefly 
responsible for regio-specific orientation of 
inositol relative to the donor saccharide. Our 
mutagenesis data also lend indirect support to 
the hypothesis that glycosyltransfer with 
retention of the -configuration of the anomeric 
carbon occurs through a substrate-mediated SNi-
type mechanism.  
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FIGURE LEGENDS 
Fig. 1 Schematic diagram of phosphatidylinositol-mannosides (PIM) and pathway of PIM 
synthesis. ManT and AraT designate generic mannosyl- and arabinosyl transferase enzymes, 
respectively. LM = lipomannan, LAM = lipoarabinomannan. 
Fig. 2 Ribbon diagram of C. glutamicum PimB' in the triclinic crystal form and comparison with 
PimA and MshA. A, N-terminal domain (blue) and C-terminal domain (green) are shown together 
with a stick model of the bound nucleotide. B, Comparison with C. glutamicum MshA (3c4v, in 
beige), after superposition with respect to secondary structure elements in the C-terminal domain. C, 
Comparison with the structure of PimA (beige) following domain-wise superposition onto PimB'. 
Beige spheres indicate the ends of the disordered 'IP-binding' loop of PimA. 
Fig. 3 Structural flexibility in the 5-5 loop and overview of the active site of PimB'. A, 
Comparison of conformation between the triclinic (green/blue) and orthorhombic crystal (grey) forms 
of PimB'. Helix 5' is only present in the orthorhombic form. B, Close-up view of the active site cleft 
of triclinic PimB' in the open configuration with ribbons in blue and green indicating the N- and C-
terminal domains, respectively. Loop regions involved in nucleotide binding are coloured in magenta. 
Residues in contact with nucleotide or that were probed by point mutagenesis are shown in yellow 
sticks. The nucleotide shown reflects the 'PimA'-like conformation of the pyrophosphate. The 
mannose moiety is shown in transparent sticks, modeled according to the conformation seen in OtsA. 
Fig. 4  Different modes of nucleotide binding in active site of PimB'. A, A-weighted Fo – Fc 
density map (contour levels 2.2  (blue) and –2.2  (red)) of triclinic PimB'. The green circle marks 
the position of the density blob corresponding to the GDP-linked mannose. B, and C, A-weighted Fo 
– Fc density maps (+2.8  (blue), -2.8  (red)) of GDP-Man (in B) and GDP-bound (in C) complexes 
of orthorhombic PimB'. Selected water molecules are labelled in blue and dashed lines in magenta 
indicate a subset of relevant non-covalent interactions. All maps were calculated with Fc amplitudes 
and phases of the ligand-free model.  
Fig. 5  Model of the closed form of PimB' with docked acceptor. A, Ribbon diagram of the closed 
configuration of PimB' superimposed with the molecular surface of the open structure of GDP-Man-
bound PimB' (orthorhombic crystal form). The dashed line  (black) indicates the approximate position 
of the membrane surface. B, Close-up view of the docked ternary complex. PIM1 (cyan bonds) is 
shown without the acyl chains and the glycerol backbone. Side chains probed by mutagenesis are 
show in blue (N-terminal domain) and green (C-terminal domain).  
Fig. 6 Activity and nucleotide binding of C. glutamicum PimB' and of selected point mutants. A, 
Analysis of transfer of [
14
C]-labeled mannose from GDP-[
14
C]Man to AcPIM1 by scintillation 
counting and thin-layer chromatography. B, Saturation binding of GDP-Man or GDP to PimB' 
monitored by internal Trp fluorescence. C, Far-UV circular dichroism spectra of wild-type PimB' and 
of the H118S mutant.   
Scheme 1 Schematic representation of steps of the SNi-like (internal return) reaction mechanism 
leading to retention of the -configuration of the anomeric carbon of the donor saccharide. Adapted 
from reference (43).  
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TABLES  
Table 1: Data acquisition and structure refinement statistics 
Data acquisition PimB' + 
GDP-Man 
SeMet 1 SeMet 2 SeMet 3 SeMet 4 PimB' + Br-
GDP-Man 
PimB' + 
GDP-Man 
PimB' + 
GDP 
Beamline ESRF  
ID29 
Diamond 
I04 
Diamond 
I04 
ESRF 
ID23.1 
ESRF  
ID29 
Diamond 
I02 
Diamond 
I04 
ESRF 
ID14.2 
Wavelength (Å) 0.9762 0.9805 0.9805 0.97905 0.97888 0.9201 0.9763 0.933 
Space group P1 P1 P1 P1 P1 P1 P212121 P212121 
Cell parameters (Å);    a, b, c = 44.1, 50.0, 
85.3 
44.1, 50.1, 
85.3 
44.1, 50.0, 
85.3 
43.9, 49.9, 
85.4 
44.0, 50.0, 
85.7 
43.9, 49.9, 
85.7 
44.8, 87.0, 
106.9 
44.8, 86.3, 
106.4 
, ,  = 92.1, 92.7, 
89.9 
92.2, 92.6, 
90.1 
92.0, 92.8, 
90.0 
91.9, 92.4, 
90.1 
92.2, 92.6, 
90.0 
92.1, 92.7, 
89.9 
90, 90, 90 90, 90, 90 
         
Resolution (Å) 44.0-2.2 29.96-2.90 29.91-2.90 25.38-2.90 29.97-2.80 29.91-2.90 37.29-2.0 45.37-2.23 
High resolution shell (Å) 2.32-2.20 3.06-2.90 3.06-2.90 3.06-2.90 2.95-2.80 3.06-2.90 2.11-2.00 2.35-2.23 
         
Rmerge (%)1), 7.3 (23.8) 4.9 (11.1) 7.1 (15.5) 6.7 (11.3) 8.5 (18.1) 11.6 (26.2) 9.6 (38) 9.3 (38.2) 
Total number of observations1) 103582 
(12352) 
40261 
(5462) 
46289 
(6804) 
44487 
(6484) 
52162 
(7446) 
46058 
(6569) 
208274 
(29919) 
64840 
(4871) 
Unique reflections1) 35191 
(4400) 
13101 
(1951) 
13931 
(2092) 
13532 
(2027) 
17456 
(2507) 
15023 
(2197) 
28997 
(4147) 
19982 
(2147) 
 I/(I) 1) 11.6 (5.9) 18.1 (7.1) 11.6 (5.3) 12.5 (7.8) 9 (5.2) 7.2 (3.2) 18.3 (5.7) 9.9 (2.3) 
Completeness (%)1) 95.1 (81.2) 81 (83.1) 86.4 (89.3) 84 (86.4) 97.4 (95.8) 93.4 (93.4) 100 (99.8) 95.8 (72.5) 
Multiplicity1) 2.9 (2.8) 3.1 (2.8) 3.3 (3.3) 3.3 (3.2) 3 (3) 
 
3.1 (3.0) 7.2 (7.2) 3.2 (2.3) 
       
Anomalous completeness (%)1)  70.5 (70.0) 84.5 (87.1) 77.3 (80.3) 92.5 (90.1) 82.4 (82.7) 
Anomalous multiplicity1)  1.7 (1.6) 1.7 (1.7) 1.7 (1.7) 1.5 (1.5) 1.7 (1.6) 
ano correlation between half-
sets1) 
 0.483 
(0.174) 
0.272 
(0.138) 
0.265 
(0.132) 
0.246 
(0.198) 
0.101 
(0.073) 
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Table 1 (cont'd) 
Refinement PimB' + 
GDP-Man 
 
PimB' + 
GDP-Man 
(orth) 
PimB' + 
GDP 
(orth) 
Space group P1 P212121 P212121 
Resolution range (Å) 44.0-2.2 37.3-2.0 45.4-2.4 
Unique reflections 33243 27519 15991 
Rcryst (%) 18.9 20.3 19 
Rfree (%)
2) 22.1 23.2 23.6 
No. of  non-H atoms 6235 3068 3019 
Protein 5829 2829 2851 
Ligand 56 56 28 
Solvent 350 183 140 
    
RMSD bonds (Å)3) 0.008 0.007 0.007 
RMSD angles ( º)3) 1.15 1.02 1.09 
Wilson B-factor (Å2) 17.3 15.9 28 
Aver. B-factor (Å2) 13.1 14.2 20.4 
Protein 12.2 13.8 20.1 
Ligand 31.9 20.6 38.2 
Solvent 17.5 19.3 24.7 
RMSD B-factor between    
Bonded main chain atoms 0.42 0.26 0.34 
Bonded side chain atoms 1.17 0.65 0.55 
Ramachandran Plot3)    
Favoured (%) 98.7 98.1 98.0 
Outliers (no.) 0 0 0 
Table Footnotes: 1) high resolution shell in parentheses; 2)  Rfree was calculated based on 5% of reflections set aside for cross-validation; 3) deviations relative 
to ideal bond distances and angles in (53); 4) calculated using MOLPROBITY (54). 
 
 at The University of Birmingham, on February 11, 2011www.jbc.orgDownloaded from 
  17 
 
Table 2:  Activity and saturation binding for PimB' and selected point mutants. 
 GDP-Man 
Kd 
GDP 
Kd 
Activity  Residual 
Activity  
 (μM)  (M) (CPM) (%) 
WT 19.0 ±4.6 36.5 ±6.9 5528 ±979 100.0 
Blank -  -  30 ±22 0.5 
N12A 20.4 ±6.2 21.3 ±5.5 1723 ±77 31.2 
D13N 30.1 ±6.9 18.8 ±5.1 83 ±5 1.5 
D13Y -  -  16 ±0 0.3 
D13A 42.8 ±11.9 61.3 ±17.4 104 ±5 1.9 
G20W 21.9 ±6.4 46.5 ±40.2 176 ±15 3.2 
I21S 13.4 ±7.0 26.5 ±7.4 134 ±22 2.4 
I21A 56.0 ±14.5 40.9 ±8.6 110 ±5 2.0 
Q22A 60.3 ±22.8 30.6 ±6.4 788 ±218 14.3 
H118S 72.4 ±27.5 19.6 ±9.8 36 ±3 0.7 
H120S -  -  4490 ±524 81.2 
G123P 29.3 ±5.9 42.3 ±9.3 4784 ±298 86.6 
S205G 18.7 ±4.6 33.6 ±6.9 6609 ±1207 119.6 
R206S 42.7 ±9.4 72.4 ±17.2 311 ±47 5.6 
R210S 40.2 ±10.7 44.1 ±28.8 481 ±58 8.7 
K211Q 30.5 ±17.6 40.3 ±14.6 193 ±25 3.5 
E290Q 35.7 ±18.9 41.7 ±21.5 252 ±30 4.6 
E290D 55.0 ±17.7 322.7 ±518.7 162 ±14 2.9 
E290N NB  NB  59 ±16 1.1 
G291S 68.7 ±35.5 74.2 ±37.2 292 ±241 5.3 
 
Hyphen (-) = binding not assayed. NB = no binding detected. 
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